The company will become part of AddLife’s Business Area Labtech. CoaChrom will continue to operate under its own brand and with a high degree of operational independence, in line with AddLife’s decentralised business model, it states.

“CoaChrom is a fantastic addition to the AddLife family of companies. We already have a strong position in coagulation products, and CoaChrom’s specialization in advanced coagulation and industrial relationships will significantly broaden and deepen our customer offer. CoaChrom is a respected niche player with a strong culture of quality, long-term partnerships, and scientific excellence. These values fit very well with AddLife’s own culture and long-term philosophy, and we are looking forward to developing the business together,” says Kai Rantanen, Vice President Business Unit Diagnostics, AddLife.

CoaChrom

CoaChrom is an Austrian niche company focusing on advanced coagulation diagnostics for clinical laboratories and the pharmaceutical industry, with sales of approximately EUR 10 million and 10 employees. With more than three decades of experience, CoaChrom develops and supplies highly specialized assays and reagents for haemostasis diagnostics. The company has a strong reputation for scientific expertise, quality, and service, and maintains long-standing customer relationships with leading hospitals and major industrial clients.

“We have built CoaChrom with a clear focus on highly specialised, customer-specific haemostasis diagnostics, strong scientific expertise, and long-term customer relationships. Joining AddLife is a natural next step to further develop the business. AddLife’s decentralised structure and deep understanding of niche diagnostics companies were key factors in our decision. We will continue to operate independently while benefiting from the group’s broader platform, resources, and international reach. This partnership allows us to accelerate ongoing developments, expand our portfolio, and strengthen our position both in clinical diagnostics and in the pharmaceutical industry,” says Bernhard Kolmer, MD, CoaChrom says.